Repression of lncRNA-SVUGP2 Mediated by EZH2 Contributes to the Development of Non-Small Cell Lung Cancer via Brisking WNT/Β-Catenin Signal

Artificial Cells, Nanomedicine and Biotechnology - United States
doi 10.1080/21691401.2019.1648279
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Upregulated lncRNA SNHG1 Contributes to Progression of Non-Small Cell Lung Cancer Through Inhibition of miR-101-3p and Activation of WNT/Β-Catenin Signaling Pathway

Oncotarget
Oncology
2017English

MicroRNA-545 Targets ZEB2 to Inhibit the Development of Non‑small Cell Lung Cancer by Inactivating WNT/Β-Catenin Pathway

Oncology Letters
Cancer ResearchOncology
2019English

Circ-Sox4 Promotes Non-Small Cell Lung Cancer Progression by Activating the WNT/Β-Catenin Pathway

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2020English

C-CRK Proto-Oncogene Contributes to Transcriptional Repression of P120-Catenin in Non-Small Cell Lung Cancer Cells

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2011English

CtBP2 Promotes Proliferation and Reduces Drug Sensitivity in Non-Small Cell Lung Cancer via the WNT/Β-Catenin Pathway

Neoplasma
Cancer Research
2018English

Long Non-Coding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2

Clinical Cancer Research
Cancer ResearchOncology
2017English

miR-650 Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion by Targeting ING4 Through WNT-1/Β-Catenin Pathway

Oncology Letters
Cancer ResearchOncology
2019English

Overexpression of RNF146 in Non-Small Cell Lung Cancer Enhances Proliferation and Invasion of Tumors Through the WNT/Β-Catenin Signaling Pathway

PLoS ONE
Multidisciplinary
2014English

LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy